|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.11.25 - 12:03
|
Enovis Announces Third Quarter 2025 Results (GlobeNewswire EN)
|
|
|
Dallas, TX, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended October 3, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET....
|
|
|
|
|
24.10.25 - 22:15
|
Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences (GlobeNewswire EN)
|
|
|
Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today it will host an investor conference call and live webcast to discuss its third quarter 2025 financial results on Thursday, November 6th, 2025, at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, will be made available on the "Investors" section of Enovis' website at www.enovis.com. Additionally, the company also announced it will participate in the following investor conferences:...
|
|
|
08.10.25 - 14:18
|
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million (GlobeNewswire EN)
|
|
|
Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity Partners, a multi-family asset management firm based in Chicago, for consideration of up to $60 million in cash, consisting of an upfront payment of $45 million, and up to $15 million payable in the future upon the achievement of certain milestones....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|